Kenya bans HIV drug
James Macharia
Kenya’s Health Minister
The Kenyan Health ministry has directed officials across the country to stop prescribing a HIV drug linked to birth defects in HIV-positive women.
The directive signed by the Director of Medical Services Jackson Kioko, urged county health directors to ensure that pregnant and breastfeeding mothers to whom a front-line drug, dolutegravir (DTG), has been prescribed, continue their current prescription until they stop breastfeeding.
But those of child bearing age between 15 and 49 years, who are on the drug, should be given the first-line treatment Efavirenz.
In a memo to county directors of health, Dr Kioko said the drug, which was launched in the Kenyan market last year, was not recommended for pregnant and breastfeeding women “due to limited safety data”.
He, however, added that through a circular in June 2017, the ministry had recommended the use of DTG in alternative regimen for people with HIV and have intolerance to Efavirenz, people who inject drugs and are on anti-retroviral therapy or new patients in the same category.
– Daily Nation
About author
You might also like
World Malaria Day: Global partnership tasks countries on timely action against malaria
The Roll Back Malaria (RBM), a partnership towards ending malaria, has called on countries to act and save almost 400,000 additional lives from malaria, even as the world was grappled
Orange, Gavi, Côte d’Ivoire join forces to boost child immunisation
Digital Network operator, Orange, and Gavi, the Vaccine Alliance are set enter into a partnership with the Côte d’Ivoire Ministry of Health to increase immunisation rates in the regions and
NAFDAC alerts on five contaminated cough syrups
The National Agency for Food and Drugs Administration and Control (NAFDAC) has warned Nigerians against five contaminated cough syrups detected in the Maldives and Pakistan. In a public alert, Mojisola
0 Comments
No Comments Yet!
You can be first to comment this post!